The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

Share Price Information for Tyman (TYMN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 367.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 3.00 (0.816%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 367.00
TYMN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD)

29 Apr 2024 12:32

RNS Number : 4376M
Quanex Building Products Corp
29 April 2024
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Quanex Building Products Corporation ("Quanex")

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Quanex Building Products Corporation

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

29 April 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

units of common stock

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

NIL

 

NIL

 

NIL

 

NIL

 

(2) Cash-settled derivatives:

 

NIL

 

NIL

 

NIL

 

NIL

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

NIL

NIL

NIL

NIL

 

TOTAL:

NIL

NIL

NIL

NIL

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) The following directors of Quanex Building Products Corporation (including their close relatives and family trusts) have interests in the following securities in Quanex:

 

Quanex Director

Number of common stock units

Percentage of total Quanex share capital

George L. Wilson

233,1541

0.704%

Curtis M. Stevens

5,009

0.015%

Jason D. Lippert

20,450

0.062%

 

1 This figure includes 92,800 unvested restricted stock awards, of which 29,200 were granted on 7 December 2023, 34,100 were granted on 7 December 2022 and 29,500 were granted on 9 December 2021. Such stock is issued (with all rights attaching) to the holder on the date of grant on a conditional basis. Such unvested restricted stock awards are not transferrable prior to the vesting date, which in each case is the date which is 3 years from the date of grant (the "Restricted Period"). Pro rata early vesting occurs upon retirement, and full early vesting occurs on change in control, death, or disability. During the Restricted Period, the holder has voting rights but does not receive dividends. Dividends are accrued during the Restricted Period and are paid only when the shares vest.

 

(b) The following directors have interests in securities in Quanex pursuant to exercisable but unexercised options:

 

Quanex Director

Number of common stock units

Grant Date

Exercise period

Exercise price

George L. Wilson

17,100

30.11.2016

30.11.2026

$19.45

14,400

02.12.2015

02.12.2025

$19.31

6,300

03.12.2014

03.12.2024

$20.28

 

(c) The following directors have interests in securities in Quanex pursuant to unvested performance restricted stock unit awards:

 

Quanex Director

Number of common stock units

Grant date

Vesting Date

George L. Wilson

25,700

07.12.2023

07.12.2026

30,400

07.12.2022

07.12.2025

29,200

09.12.2021

09.12.2024

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

29 April 2024

Contact name:

Scott Zuehlke

Telephone number:

+1 713 877 5327

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEQKCBBDBKDFQB
Date   Source Headline
3rd Jun 20207:00 amRNSHolding(s) in Company
21st May 20203:30 pmRNSHolding(s) in Company
20th May 202010:40 amRNSResult of AGM
20th May 20207:00 amRNSAnnual General Meeting Trading and COVID-19 Update
4th May 20204:14 pmRNSDirector/PDMR Shareholding
17th Apr 20202:33 pmRNSHolding(s) in Company
8th Apr 20207:00 amRNSNotice of AGM
3rd Apr 20203:07 pmRNSDirector/PDMR Shareholding
3rd Apr 20207:00 amRNSCOVID-19 and Dividend Update
26th Mar 20207:00 amRNSDirector/PDMR Shareholding
20th Mar 20204:31 pmRNSDirector/PDMR Shareholding
17th Mar 20204:37 pmRNSPrice Monitoring Extension
10th Mar 202011:46 amRNSHolding(s) in Company
6th Mar 20205:28 pmRNSHolding(s) in Company
5th Mar 202012:23 pmRNSDirector/PDMR Shareholding
5th Mar 20207:00 amRNSFinal Results
23rd Jan 202011:49 amRNSHolding(s) in Company
12th Dec 20197:04 amRNSDirectorate Change
18th Nov 20193:34 pmRNSHolding(s) in Company
6th Nov 20197:00 amRNSTrading Statement
3rd Oct 201911:08 amRNSHolding(s) in Company
3rd Oct 201911:07 amRNSHolding(s) in Company
2nd Oct 201911:17 amRNSDirector/PDMR Shareholding
30th Sep 20193:29 pmRNSDirector/PDMR Shareholding
30th Sep 20193:27 pmRNSDirector/PDMR Shareholding
29th Aug 20197:00 amRNSDirector/PDMR Shareholding
21st Aug 201912:02 pmRNSPrice Monitoring Extension
7th Aug 20199:34 amRNSDirector/PDMR Shareholding
6th Aug 201912:54 pmRNSDirector/PDMR Shareholding
6th Aug 20199:37 amRNSDirector/PDMR Shareholding
25th Jul 20197:00 amRNSHalf-Year Report
5th Jun 20195:06 pmRNSCompletion of Capital Reduction
15th May 20194:20 pmRNSDirector/PDMR Shareholding
10th May 20195:37 pmRNSDirector/PDMR Shareholding
10th May 20195:37 pmRNSDirector/PDMR Shareholding
9th May 20196:06 pmRNSConfirmation of Directorate Change
9th May 20195:36 pmRNSResult of AGM
9th May 20197:00 amRNSAGM Statement
25th Apr 20197:00 amRNSDirectorate Change and 2019 AGM
1st Apr 20195:34 pmRNSAnnual Financial Report and Notice of AGM
1st Apr 20197:01 amRNSDirector/PDMR Shareholding
1st Apr 20197:00 amRNSConfirmation of Directorate Change
26th Mar 20194:56 pmRNSDirector/PDMR Shareholding
20th Mar 20195:44 pmRNSShare dealings by Tyman plc EBT
19th Mar 20196:24 pmRNSTyman 2019 LTIP Awards
19th Mar 20196:01 pmRNSDirector/PDMR Shareholding
19th Mar 20196:00 pmRNSDirector/PDMR Shareholding
19th Mar 20195:59 pmRNSDirector/PDMR Shareholding
19th Mar 20195:58 pmRNSDirector/PDMR Shareholding
19th Mar 20195:51 pmRNSShare dealings by Tyman plc EBT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.